tiprankstipranks
Bristol-Myers Squibb (DE:BRM)
XETRA:BRM

Bristol-Myers Squibb (BRM) Financial Statements

14 Followers

Bristol-Myers Squibb Financial Overview

Bristol-Myers Squibb's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; and it has a dividend yield of 4.39%. Bristol-Myers Squibb is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is €1.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 11.48B$ 10.97B$ 10.92B$ 11.34B$ 11.41B
Gross Profit$ 8.73B$ 8.46B$ 10.77B$ 6.44B$ 8.81B
EBIT$ 1.11B$ 2.42B$ 2.14B$ 2.16B$ 2.15B
EBITDA$ 3.58B$ 4.85B$ 4.57B$ 4.59B$ 4.67B
Net Income Common Stockholders$ 1.76B$ 6.61B$ 2.07B$ 2.27B$ 2.02B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.28B$ 8.01B$ 8.73B$ 9.27B$ 9.25B
Total Assets$ 95.16B$ 91.26B$ 93.49B$ 94.28B$ 96.82B
Total Debt$ 39.77B$ 37.60B$ 37.68B$ 37.83B$ 40.72B
Net Debt$ 27.49B$ 29.59B$ 28.95B$ 28.56B$ 31.46B
Total Liabilities$ 65.67B$ 62.20B$ 61.46B$ 62.40B$ 65.70B
Stockholders Equity$ 29.43B$ 29.00B$ 31.97B$ 31.82B$ 31.06B
Cash Flow-
Free Cash Flow$ 3.92B$ 4.41B$ 1.63B$ 2.69B$ 2.96B
Operating Cash Flow$ 4.25B$ 4.75B$ 1.89B$ 2.97B$ 3.31B
Investing Cash Flow$ -1.35B$ -410.00M$ -329.00M$ -210.00M$ 1.21B
Financing Cash Flow$ 967.00M$ -5.16B$ -2.17B$ -3.05B$ -3.25B
Currency in USD

Bristol-Myers Squibb Earnings and Revenue History

Bristol-Myers Squibb Debt to Assets

Bristol-Myers Squibb Cash Flow

Bristol-Myers Squibb Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis